# Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

> **NCT01341405** · PHASE2 · COMPLETED · sponsor: **CrystalGenomics, Inc.** · enrollment: 125 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** CG100649
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT01341405
- **Lead sponsor:** CrystalGenomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341405, "Study of CG100649 Versus Celecoxib in Osteoarthritis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01341405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*